SXTC — China SXT Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for China SXT Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-5.74	-5.93	-3.1	-3.3	-6.21
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	2.89	4.19	1.35	1.85	4.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital	2.46	1.42	-0.382	-0.972	-2.39
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	0.268	-0.081	-1.93	-2.35	-4.02
Capital Expenditures	-0.062	-0.071	-0.007	-0.002	-1.25
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.016	0.058	0.033	0.066	0
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-0.047	-0.012	0.026	0.064	-1.25
Financing Cash Flow Items	-3.84	-3.26	-1.73	5.84	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	1.6	2.94	-2.62	8.4	14.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2.21	1.8	-5.29	6.05	10